Characterization of an in vitro model of alphavirus infection of immature and mature neurons.
Terminally differentiated, mature neurons are essential cells that are not easily regenerated. Neurotropic viruses, such as Sindbis virus (SV), cause encephalomyelitis through their ability to replicate in neurons. SV causes the death of immature neurons, while mature neurons can often survive infection. The lack of a reproducible and convenient neuronal cell culture system has hindered a detailed study of the differences in levels of virus replication between immature and mature neurons and the molecular events involved in virus clearance from mature neurons. We have characterized SV replication in immortalized CSM14.1 rat neuronal cells that can be differentiated into neurons. During differentiation, CSM14.1 cells ceased dividing, developed neuronal morphology, and expressed neuron-specific cell markers. SV infection of undifferentiated CSM14.1 cells was efficient and resulted in high levels of virus replication and cell death. SV infection of differentiated CSM14.1 cells was less efficient and resulted in the production of 10- to 100-fold less virus and cell survival. In undifferentiated cells, SV induced a rapid shutdown of cellular protein synthesis and pE2 was efficiently processed to E2 (ratio of E2 to pE2, 2.14). In differentiated cells, the SV-induced shutdown of cellular protein synthesis was transient and pE2 was the primary form of E2 in cells (ratio of E2 to pE2, 0.0426). We conclude that age-dependent restriction of virus replication is an intrinsic property of maturing neurons and that the CSM14.1 cell line is a convenient model system for investigating the interactions of alphaviruses with neurons at various stages of differentiation.
Vernon
Patty S
PS
W. Harry Feinstone Department of Molecular Microbiology and Immunology, Johns Hopkins Bloomberg School of Public Health, 615 North Wolfe St., Baltimore, MD 21205, USA.
Griffin
Diane E
DE
D000818:Animals; D002454:Cell Differentiation; D002460:Cell Line; D003588:Cytopathogenic Effect, Viral; D008562:Membrane Glycoproteins / Q000096:biosynthesis; D009474:Neurons / Q000166:cytology / Q000821:virology*; D014176:Protein Biosynthesis; D011498:Protein Precursors / Q000096:biosynthesis; D011506:Proteins / Q000378:metabolism; D051381:Rats; D012845:Sindbis Virus / Q000502:physiology*; D014759:Viral Envelope Proteins / Q000096:biosynthesis; D010948:Viral Plaque Assay; D014764:Viral Proteins / Q000096:biosynthesis; D014779:Virus Replication
D008562:Membrane Glycoproteins; D011498:Protein Precursors; D011506:Proteins; D014759:Viral Envelope Proteins; D014764:Viral Proteins; C064950:glycoprotein E2, Sindbis virus; C102373:glycoprotein PE2, Sindbis virus
J Exp Med. 1981 Jul 1;154(1):199-203
6166723
JAMA. 2003 Jul 23;290(4):511-5
12876094
Vet Pathol. 1983 Jan;20(1):49-56
6681574
Ann Neurol. 1983 Jun;13(6):602-7
6309071
Arch Virol. 1983;78(3-4):303-8
6318700
Acta Neuropathol. 1986;72(1):43-54
3548203
J Neurol Sci. 1987 Nov;81(2-3):227-37
2826706
Lab Invest. 1988 May;58(5):503-9
3367635
J Virol. 1988 Jul;62(7):2329-36
2836615
J Virol. 1991 Feb;65(2):880-6
1987378
J Virol. 1991 Mar;65(3):1551-7
1995953
J Virol. 1991 Dec;65(12):6913-21
1658382
Science. 1991 Nov 8;254(5033):856-60
1658936
Nature. 1993 Feb 25;361(6414):739-42
8441470
Proc Natl Acad Sci U S A. 1993 May 15;90(10):4533-7
8506295
Arch Virol. 1993;130(3-4):477-84
8517798
J Virol. 1993 Aug;67(8):4605-10
8392602
Virology. 1993 Aug;195(2):627-37
8393239
Brain Res Mol Brain Res. 1993 Sep;19(4):353-5
7901730
Arch Virol Suppl. 1994;9:31-9
8032263
Microbiol Rev. 1994 Sep;58(3):491-562
7968923
J Virol. 1995 Mar;69(3):1990-3
7853547
Curr Top Microbiol Immunol. 1995;191:117-34
7789155
Arch Virol. 1995;140(5):915-25
7605202
J Virol. 1995 Nov;69(11):7006-14
7474120
J Virol. 1995 Nov;69(11):7345-8
7474167
J Virol. 1996 Mar;70(3):1828-35
8627707
J Neurovirol. 1997 Feb;3(1):38-48
9147820
N Engl J Med. 1997 Jun 26;336(26):1867-74
9197215
Brain Res. 1997 Oct 3;770(1-2):163-8
9372215
Immunol Rev. 1997 Oct;159:155-61
9416509
Neuroscience. 1998 Feb;82(3):867-77
9483542
Neurosci Biobehav Rev. 1998 Oct;22(6):721-3
9809307
Hum Mol Genet. 1999 Jul;8(7):1169-76
10369861
J Virol. 2000 Jul;74(13):6156-61
10846099
Methods Enzymol. 2000;322:492-508
10914042
J Neuropathol Exp Neurol. 2001 May;60(5):449-61
11379820
J Virol. 2001 Aug;75(15):7114-21
11435592
Science. 2001 Jul 13;293(5528):303-6
11452126
J Neurosci. 2001 Aug 1;21(15):5389-96
11466410
Cell Death Differ. 2002 Apr;9(4):405-13
11965493
J Virol. 2002 Sep;76(17):8842-54
12163604
J Anat. 2002 Jul;201(1):61-9
12171477
J Virol. 2002 Nov;76(22):11254-64
12388685
J Virol. 2002 Nov;76(22):11688-703
12388728
J Neurovirol. 2002 Dec;8 Suppl 2:66-74
12491154
J Neurovirol. 2002 Dec;8 Suppl 2:112-4
12491161
Virology. 2002 Nov 25;303(2):222-31
12490385
Virology. 2003 Feb 15;306(2):268-79
12642100
Virology. 2003 Jun 20;311(1):28-39
12832200
Mol Cell Biochem. 2003 Jun;248(1-2):97-102
12870660
J Virol. 2004 Apr;78(7):3644-53
15016885
J Infect Dis. 1972 Mar;125(3):257-62
4552644
Infect Immun. 1974 Apr;9(4):690-5
4132617
J Infect Dis. 1976 Apr;133(4):456-64
1262711
Jpn J Exp Med. 1977 Apr;47(2):109-15
194073
Curr Top Microbiol Immunol. 1981;92:25-52
6171385